REVIEW （2016年02期）

1. Programmed cell death ligand-1 （PD-L1） expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer？
2. Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies

1. Immuno-oncology combinations: raising the tail of the survival curve
2. Nonmuscle invasive bladder cancer: a primer on immunotherapy
3. Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward？
4. New generation of breast cancer clinical trials implementing molecular profiling
5. Genetic and molecular changes in ovarian cancer
6. Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang
7. Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients
8. Influence of obesity and bariatric surgery on gastric cancer
9. Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignancies
10. The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands

ORIGINAL ARTICLE

1. Table of Contents